Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma
Status:
Suspended
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
This phase I trial evaluates the feasibility of using hyperpolarized carbon C 13 pyruvate
magnetic resonance imaging (MRI) in diagnosing patients with primary central nervous system
lymphoma. This trial aims to see whether MRI using hyperpolarized carbon-13 pyruvate is safe
and useful for detecting central nervous system lymphoma and evaluating response to
treatment.